Immatics Future Growth

Future criteria checks 0/6

Immatics's revenue and earnings are forecast to decline at 5.1% and 22.8% per annum respectively while EPS is expected to decline by 17.2% per annum.

Key information

-22.8%

Earnings growth rate

-17.2%

EPS growth rate

Biotechs earnings growth42.4%
Revenue growth rate-5.1%
Future return on equityn/a
Analyst coverage

Good

Last updated22 Nov 2024

Recent future growth updates

Recent updates

Earnings and Revenue Growth Forecasts

DB:4A3 - Analysts future estimates and past financials data (EUR Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202650-160-183N/A5
12/31/202561-137-144N/A7
12/31/2024116-63-134N/A6
9/30/2024116-56-45-20N/A
6/30/202471-74-45-17N/A
3/31/202474-80-269N/A
12/31/202354-97-1318N/A
9/30/202376-84-117-92N/A
6/30/202385-79-113-94N/A
3/31/202380-68-40-31N/A
12/31/20221733894100N/A
9/30/20221513497102N/A
6/30/202214228113119N/A
3/31/2022130153844N/A
12/31/202135-93-90-85N/A
9/30/202128-95-86-81N/A
6/30/202130-231-133-127N/A
3/31/202132-226-97-91N/A
12/31/202031-211-88-81N/A
9/30/202026-208-38-31N/A
6/30/202023-497581N/A
3/31/202022-345560N/A
12/31/201918-326971N/A
12/31/20184-312021N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 4A3 is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: 4A3 is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: 4A3 is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: 4A3's revenue is expected to decline over the next 3 years (-5.1% per year).

High Growth Revenue: 4A3's revenue is forecast to decline over the next 3 years (-5.1% per year).


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if 4A3's Return on Equity is forecast to be high in 3 years time


Discover growth companies